{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:57:41Z","timestamp":1784185061444,"version":"3.55.0"},"reference-count":40,"publisher":"BMJ","issue":"4","funder":[{"name":"Dallas Fort Worth Living Legend Professorship","award":["no award\/grant number"],"award-info":[{"award-number":["no award\/grant number"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA214960"],"award-info":[{"award-number":["R01CA214960"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA231471"],"award-info":[{"award-number":["R01CA231471"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA288515"],"award-info":[{"award-number":["R01CA288515"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2025,9,15]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Exertional dyspnoea is highly debilitating. Previous single-dose studies found that prophylactic administration of fentanyl buccal tablet (FBT) improved exertional dyspnoea. In this randomised trial, we compared daily use of prophylactic FBT, oral morphine and placebo on exertional dyspnoea over 14 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This parallel, double-blind, randomised clinical trial enrolled opioid-tolerant patients with cancer and exertional dyspnoea. After a 5-day observation period, patients were randomised (1:1:1) to receive FBT, morphine or placebo 30\u2009min before daily structured activity for 14 days. Shuttle walk tests (SWTs) were conducted on days 1\/5\/8\/12\/15\/19. The primary outcome was change in modified Borg Scale dyspnoea intensity during SWTs from day 5 to day 19, analysed using a mixed effects model with treatment, time and treatment\u00d7time interaction. SWT distance was a key secondary outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>67 patients were enrolled and 56 (84%) were randomised. Over the 14-day blinded phase, we observed a significant decrease in the magnitude of dyspnoea intensity change during the SWTs in all three groups, with no significant difference by treatment group (slope change from day 5 to day 19: FBT \u22122.2 (95% CI \u22122.9 to \u20131.6); morphine \u22121.9 (95% CI \u22122.7 to \u20131.2); placebo \u22122.2 (95% CI \u22123 to \u20131.4); time effect p&lt;0.001, treatment\u00d7time effect p=0.79). SWT distance increased significantly over time (FBT +93\u2009m; morphine +84\u2009m; placebo +76\u2009m) but did not differ by treatment (p=0.71). Few adverse events were reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>All three groups reported less dyspnoea while walking farther; however, no difference was detected between opioids and placebo. These findings should be considered preliminary given the underpowered sample.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04188418\">NCT04188418<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2025-222970","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:20:26Z","timestamp":1760980826000},"page":"344-356","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of fentanyl buccal tablet and morphine for exertional dyspnoea in patients with cancer: a double-blind, placebo-controlled, randomised clinical trial"],"prefix":"10.1136","volume":"81","clinical-trial-number":[{"clinical-trial-number":"nct04188418","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04188418","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2733-6607","authenticated-orcid":false,"given":"David","family":"Hui","sequence":"first","affiliation":[{"name":"Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"},{"name":"Center for Goal Concordant Care Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"},{"name":"Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraira","family":"Pacheco","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, John P and Katherine G McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, John P and Katherine G McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristofer","family":"Jennings","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"de la Cruz","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Stanton","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Laureano","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7013-4586","authenticated-orcid":false,"given":"Amy","family":"Ontai","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Mahler","sequence":"additional","affiliation":[{"name":"Dartmouth College Geisel School of Medicine, Hanover, New Hampshire, USA"},{"name":"Respiratory Services, Valley Regional Hospital, Claremont, New Hampshire, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"2026042806000679000_81.4.344.1","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2008.0158"},{"key":"2026042806000679000_81.4.344.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2012.02.022"},{"key":"2026042806000679000_81.4.344.3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1017\/S1478951507000454","article-title":"Experiences of breathlessness: a systematic review of the qualitative literature","volume":"5","author":"Gysels","year":"2007","journal-title":"Palliat Support Care"},{"key":"2026042806000679000_81.4.344.4","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.20.03465","article-title":"Management of Dyspnea in Advanced Cancer: ASCO Guideline","volume":"39","author":"Hui","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026042806000679000_81.4.344.5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6366.675"},{"key":"2026042806000679000_81.4.344.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00446-9"},{"key":"2026042806000679000_81.4.344.7","doi-asserted-by":"crossref","first-page":"29051274","DOI":"10.1183\/13993003.01235-2017","article-title":"Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial","volume":"50","author":"Abdallah","year":"2017","journal-title":"Eur Respir J"},{"key":"2026042806000679000_81.4.344.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2013.03.017"},{"key":"2026042806000679000_81.4.344.9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jpainsymman.2016.05.013","article-title":"Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial","volume":"52","author":"Hui","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"2026042806000679000_81.4.344.10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jpainsymman.2017.08.001","article-title":"Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial","volume":"54","author":"Hui","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"2026042806000679000_81.4.344.11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jpainsymman.2019.06.024","article-title":"Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial","volume":"58","author":"Hui","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"2026042806000679000_81.4.344.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198112313052703"},{"key":"2026042806000679000_81.4.344.13","doi-asserted-by":"publisher","DOI":"10.1177\/0269216307076398"},{"key":"2026042806000679000_81.4.344.14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4037\/ajcc1998.7.3.200","article-title":"Validity of the numeric rating scale as a measure of dyspnea","volume":"7","author":"Gift","year":"1998","journal-title":"Am J Crit Care"},{"key":"2026042806000679000_81.4.344.15","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2012.0364"},{"key":"2026042806000679000_81.4.344.16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1984.2.3.187"},{"key":"2026042806000679000_81.4.344.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(96)00316-8"},{"key":"2026042806000679000_81.4.344.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.07.026"},{"key":"2026042806000679000_81.4.344.19","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1002"},{"key":"2026042806000679000_81.4.344.20","doi-asserted-by":"crossref","unstructured":"American Thoracic Society\/European Respiratory S . ATS\/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002;518\u2013624. doi:10.1164\/rccm.166.4.518","DOI":"10.1164\/rccm.166.4.518"},{"key":"2026042806000679000_81.4.344.21","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.2.146"},{"key":"2026042806000679000_81.4.344.22","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00150314"},{"key":"2026042806000679000_81.4.344.23","doi-asserted-by":"publisher","DOI":"10.1136\/thx.47.12.1019"},{"key":"2026042806000679000_81.4.344.24","doi-asserted-by":"publisher","DOI":"10.1081\/COPD-200050655"},{"key":"2026042806000679000_81.4.344.25","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201907-563RL"},{"key":"2026042806000679000_81.4.344.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6132.241"},{"key":"2026042806000679000_81.4.344.27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jpainsymman.2016.10.370","article-title":"The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments","volume":"53","author":"Hui","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"2026042806000679000_81.4.344.28","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x"},{"key":"2026042806000679000_81.4.344.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-012-2954-z"},{"key":"2026042806000679000_81.4.344.30","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90053-E"},{"key":"2026042806000679000_81.4.344.31","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0265-2023","article-title":"Opioids for the palliation of symptoms in people with serious respiratory illness: a systematic review and meta-analysis","volume":"33","author":"Smallwood","year":"2024","journal-title":"Eur Respir Rev"},{"key":"2026042806000679000_81.4.344.32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/SPC.0000000000000509","article-title":"Use of short-acting opioids in the management of breathlessness: an evidence-based review","volume":"14","author":"Hui","year":"2020","journal-title":"Curr Opin Support Palliat Care"},{"key":"2026042806000679000_81.4.344.33","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1152\/japplphysiol.00303.2022","article-title":"Lower-limb resistance training reduces exertional dyspnea and intrinsic neuromuscular fatigability in individuals with chronic obstructive pulmonary disease","volume":"134","author":"Brunton","year":"2023","journal-title":"J Appl Physiol"},{"key":"2026042806000679000_81.4.344.34","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.6.1794"},{"key":"2026042806000679000_81.4.344.35","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S1470-2045(22)00508-3","article-title":"Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial","volume":"23","author":"Hui","year":"2022","journal-title":"Lancet Oncol"},{"key":"2026042806000679000_81.4.344.36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jpainsymman.2020.12.023","article-title":"Fixed-Dose Netupitant and Palonosetron for Chronic Nausea in Cancer Patients: A Double-Blind, Placebo Run-in Pilot Randomized Clinical Trial","volume":"62","author":"Hui","year":"2021","journal-title":"J Pain Symptom Manage"},{"key":"2026042806000679000_81.4.344.37","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.8506"},{"key":"2026042806000679000_81.4.344.38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jpainsymman.2024.07.003","article-title":"Predictive Biomarkers of Dyspnea Response to Dexamethasone and Placebo in Cancer Patients","volume":"68","author":"Hui","year":"2024","journal-title":"J Pain Symptom Manage"},{"key":"2026042806000679000_81.4.344.39","article-title":"Trends in Outpatient Opioid Prescriptions for Cancer Pain Between 2016 and 2021","volume":"PubMed Central PMCID","author":"Admane","year":"2025","journal-title":"JCO Oncol Pract"},{"key":"2026042806000679000_81.4.344.40","first-page":"5645","article-title":"A systematic review of assessment approaches to predict opioid misuse in people with cancer","volume":"30","author":"Keall","year":"2022","journal-title":"Support Care Cancer"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2025-222970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:01:05Z","timestamp":1777381265000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2025-222970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,3,13]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/thorax-2025-222970"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2025-222970","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]}}}